This filing demonstrates the development of its manual rates in support of MVP Health Insurance Company’s (MVP) Large Group AR42 product portfolio and seeks approval of the manual rates, experience rating formula, and factors used to develop group specific premium rates to be used in the third and fourth quarter of 2016.
Docket No. GMCB-004-16rr
SERFF No. MVPH-130454426
Date Posted to Web: 02/23/16
HCA Memorandum in Lieu of Hearing
MVP Memorandum in Lieu of Hearing
Hearing Waived on 04/25/16 per MVP and the HCA